CignaCI

NYSE

Health Insurance

$276.00-0.25%

Launch Multi-Agent Real-Time Command Center Launch 8-Agent Deep Analysis

AI Multi-Horizon Analysis

Short-term72% confidence

Bearish

1m内价格跌破EMA12/26，MACD柱正转负，成交量放大，短期向下动能强。

Mid-term65% confidence

Bearish

1H/1D双周期均线空头，RSI低于40，内部人连续净卖出，未来1-2日易回落至270附近。

Long-term55% confidence

Neutral

1W/1mo周期价格仍处于长期上升通道，Q2收入环比回升，长期趋势未被破坏，但需观察270-280区间突破方向。

Overall AI View68% confidence

Bearish

1H与1D多周期均线空头排列，MACD转负，RSI跌至超卖区间，叠加内部人净卖出，短期压力显著。

Detailed AI Fundamental Analysis

This analysis was originally written in Chinese (China). No matching English run is cached yet — kick off a live analysis above to generate one.

业务速览

The Cigna Group（Ticker: CI）为在 NYSE 上市的普通股，交易货币为 USD；行业分类未提供。
当前价格为 275.01。市场处于盘前，当前活跃周期为 1H。
价格近期波动显著：1H 区间为 272.08–305.44，1D 区间为 239.51–311.34；1D ATR 为 9.3854，1W ATR 为 16.8581，短线风险较高。
由于未提供公司业务分部、管理层指引、估值倍数或分析师目标价，以下判断主要基于财务趋势、内部人数据和价格行为。

财务趋势

收入轨迹： 最新季度 2026-06-30 收入为 71,668,000,000，较 2026-03-31 的 68,494,000,000 增加 3,174,000,000，增幅约 4.6%。与 2025-09-30 的 69,748,000,000 相比，最新季度增加 1,920,000,000，增幅约 2.8%。收入整体保持高位并在最新季度环比回升，但未显示出连续

Financials

From SEC EDGAR · Period 2026-06-30 · Source form 10-Q

Income Statement · last 4 periods

	2026-06-30 10-Q	2026-03-31 10-Q	2025-12-31 10-K	2025-09-30 10-Q
Revenue	$71.67B	$68.49B	$274.90B	$69.75B
Operating Income	$2.68B	$2.36B	$9.20B	$2.58B
Net Income	$1.66B	$1.65B	$5.96B	$1.97B
EPS (Diluted)	$6.29	$6.26	$22.18	$6.98
Operating Margin	3.73%	3.44%	3.35%	3.70%
Net Margin	2.32%	2.41%	2.17%	2.83%

Balance Sheet · last 4 periods

	2026-06-30 10-Q	2026-03-31 10-Q	2025-12-31 10-Q	2025-09-30 10-Q
Total Assets	$157.08B	$153.27B	$157.92B	$157.92B
Total Liabilities	$114.17B	$110.82B	$116.05B	$115.91B
Shareholders' Equity	$42.62B	$42.21B	$41.71B	$41.80B
Cash & Equivalents	$6.30B	$7.04B	$7.68B	$6.03B
Long-term Debt	$29.09B	$29.37B	$30.87B	$30.95B
Current Ratio	0.85	0.82	0.85	0.83
Debt / Equity	0.68	0.70	0.74	0.74

Cash Flow · last 4 periods

	2026-06-30 10-Q	2026-03-31 10-Q	2025-12-31 10-K	2025-09-30 10-Q
Cash from Operations	$710.00M	$1.13B	$9.60B	$3.45B
Cash from Investing	-$1.14B	-$637.00M	-$4.41B	-$3.99B
Cash from Financing	-$934.00M	-$1.14B	-$6.42B	-$2.35B

Income Statement

Revenue: $140.16B
Gross Profit: —
Operating Income: $5.03B
Net Income: $3.31B
EPS (Basic): $12.61
EPS (Diluted): $12.55

Balance Sheet

Total Assets: $157.08B
Total Liabilities: $114.17B
Shareholders' Equity: $42.62B
Cash & Equivalents: $6.30B
Long-term Debt: $39.52B
Shares Outstanding: 264.24M

Cash Flow

Cash from Operations: $710.00M
Cash from Investing: -$1.14B
Cash from Financing: -$934.00M
Capital Expenditures: $740.00M
Free Cash Flow: -$30.00M

Key Ratios

Gross Margin

—

Operating Margin

3.59%

Net Margin

2.36%

Current Ratio

0.85

Debt / Equity

0.93

Free Cash Flow

-$30.00M

Key Stats

$72.95BMarket cap

$350.0052-week high

$239.5152-week low

1,597,362Avg volume (30d)

67,700 employees263.66M shares outstandinglisted 1982-04-01dividend yield 2.19%

Next earnings ~May 5, 2026 · Ex-dividend Jun 4, 2026 · Dividend $1.56 quarterly

About Cigna

Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is with the Department of Defense, and it recently won a multiyear deal with top-tier insurer Centene. In health insurance and other benefits, Cigna primarily serves employers through self-funding arrangements, and the company operates mostly in the US with 16 million US and 2 million international medical members covered as of December 2025.

https://www.thecignagroup.com